Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT02299375 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Losmapimod tablets
DRUG: Placebo tablets
DRUG: Salbutamol MDI

Sponsor

GlaxoSmithKline